Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

President Trump will introduce a "most favored nation" plan aimed at cutting Medicare drug prices by linking them to the ...

According to recent reporting, Gov. Josh Shapiro is considering cutting off access to the weight loss drugs like Zepbound and Wegovy to all Medicaid recipients in the state who are not dangerously ...

Investors are betting that Lilly will maintain its momentum. Its share price has climbed by a third since the start of 2024; ...

U.S. drug distributor Cencora raised its annual profit forecast on Wednesday, driven by robust demand for costly specialty medicines and weight-loss drugs.

Weight-loss medications such as Ozempic, Wegovy, and Mounjaro have attracted widespread attention, making headlines across ...

Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...

CVS reported first quarter earnings Thursday, blowing past Wall Street's expectations and ending anxiety over Medicare ...

The New Beginnings Weight Loss Program is tailored for people with a BMI over 30 who are ready to embark on a journey toward ...

The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...

Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent ...

Weight loss drugs are a revolution for people who are seriously obese, but shouldn't we take a look at the ultra-processed foods causing our health problems first?